Based on technology licensed several years ago from Elan, Merrion Pharma (Wilmington, NC) has been developing a variety of drug formulations that convert an injectable or infusible drug into a pill. One of these, the bisphosphonate zoledronate (sold by Novartis […]
Read MoreThe combination of a global financial crisis, a recession in most parts of the world, and wildly unstable fuel prices are pounding the economic outlooks of most third-party logistics (3PL) companies, according to an annual report from Armstrong & Associates […]
Read MoreSupply chain cost and regulation occupy top share of mind among decisionmakers at biopharma and med device companies, according to a survey conducted by Harris Interactive on behalf of UPS. The survey, now in its second year, is meant to […]
Read MoreSurprise! Oracle now leads SAP in application revenue within life sciences, according to a study completed by IDC Health Industry Insights (Framingham, MA) in May. It’s not that SAP, whose ERP and financial systems are widely used throughout the corporate […]
Read MoreWith slowing growth and more resistance from payers, global pharmaceutical companies are under pressure to streamline expenses and accelerate development of products with demonstrable therapeutic value that will produce sustainable revenue growth and margins. Companies that want doctors to continue […]
Read MoreWhile each of the Big Three wholesalers make a bid for independent pharmacy business, AmerisourceBergen is still generally regarded as the company most closely aligned with that channel. About half of its retail pharmacy customers belong to its Good Neighbor […]
Read MoreNow in its fifth year as organized by Fuld & Co. (Cambridge MA), a type of competitive analysis known as war-gaming identified McKesson as a potential winner when the business environment for EMRs becomes established. Fuld & Co. sets up […]
Read MoreCegedim Dendrite (Bedminster, NJ) is one of several firms now offering a service that tracks the proliferation of state-level rules on reporting gifts, sponsorships or other marketing activities that occur between manufacturers and healthcare providers. A chart from Cegedim Dendrite’s […]
Read MoreOver the past 20 years, pharmaceutical contracting has been transformed from being a small incremental part of the typical pharmaceutical manufacturer’s business to one that is integral to almost every market segment. In many cases, filling a conventional prescription invokes […]
Read MorePharmacy benefit manager (PBM) Medco Health Solutions’ annual Drug Trend Report summarizes utilization, cost and product mix for the company’s 60 million consumes, who received 586 million prescriptions from the company, representing about a fifth of the national pharmaceutical market. […]
Read More